Nasmed Ozel Saglik Hizmetleri Ticaret AS Asset Resilience Ratio

Latest as of December 2023: 1.30%

Nasmed Ozel Saglik Hizmetleri Ticaret AS asset resilience ratio. Nasmed Ozel Saglik Hizmetleri Ticaret AS (EGEPO) has an Asset Resilience Ratio of 1.30% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Nasmed Ozel Saglik Hizmetleri Ticaret AS to measure how many days the company can operate on defensive assets alone.

Liquid Assets

TL23.73 Million
≈ $531.52K USD Cash + Short-term Investments

Total Assets

TL1.83 Billion
≈ $40.94 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Nasmed Ozel Saglik Hizmetleri Ticaret AS (2022–2023)

Asset resilience ratio of Nasmed Ozel Saglik Hizmetleri Ticaret AS from 2022 to 2023. This chart shows how Nasmed Ozel Saglik Hizmetleri Ticaret AS's Asset Resilience Ratio has changed over time. Read EGEPO liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Nasmed Ozel Saglik Hizmetleri Ticaret AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see EGEPO current and non-current assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents TL0.00 0%
Short-term Investments TL23.73 Million 1.3%
Total Liquid Assets TL23.73 Million 1.30%

Asset Resilience Insights

  • Limited Liquidity: Nasmed Ozel Saglik Hizmetleri Ticaret AS maintains only 1.30% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Nasmed Ozel Saglik Hizmetleri Ticaret AS Industry Peers by Asset Resilience Ratio

Compare Nasmed Ozel Saglik Hizmetleri Ticaret AS's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MLP Saglik Hizmetleri AS
IS:MPARK
Medical Care Facilities 0.99%
WELL Health Technologies Corp
TO:WELL
Medical Care Facilities 4.09%
Chularat Hospital Public Company Limited
BK:CHG-R
Medical Care Facilities 0.88%
Pacific Smiles Group Ltd
AU:PSQ
Medical Care Facilities 10.35%
Sarana Meditama Metropolitan
JK:SAME
Medical Care Facilities 0.00%
Ramsay Health Care Ltd
AU:RHC
Medical Care Facilities 3.49%
Regis Healthcare Ltd
AU:REG
Medical Care Facilities 2.29%
Oceania Healthcare Ltd
AU:OCA
Medical Care Facilities 0.01%

Nasmed Ozel Saglik Hizmetleri Ticaret AS Asset Resilience Ratio by Year (2022–2023)

Nasmed Ozel Saglik Hizmetleri Ticaret AS asset resilience ratio by year from 2022 to 2023. The table below shows the annual Asset Resilience Ratio data for Nasmed Ozel Saglik Hizmetleri Ticaret AS.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 1.30% TL23.73 Million
≈ $531.52K
TL1.83 Billion
≈ $40.94 Million
-3.37pp
2022-12-31 4.67% TL22.18 Million
≈ $496.81K
TL474.97 Million
≈ $10.64 Million
--
pp = percentage points

About Nasmed Ozel Saglik Hizmetleri Ticaret AS

IS:EGEPO Turkey Medical Care Facilities
Market Cap
$49.27 Million
TL2.20 Billion TRY
Market Cap Rank
#21707 Global
#294 in Turkey
Share Price
TL4.40
Change (1 day)
-0.90%
52-Week Range
TL3.74 - TL19.92
All Time High
TL32.10
About

Nasmed Özel Saglik Hizmetleri Ticaret Anonim Sirketi provides healthcare services in Turkey. The company's medical units include oral and dental health; anesthesiology and reanimation; nutrition and diet; brain and nerve surgery; childhood diseases; dermatology; endocrinology and metabolic diseases; infectious diseases and clinical microbiology; aesthetic, plastic, and reconstructive surgery; hom… Read more